Yaoqin Gong

Yaoqin Gong

Auto-generated profile, based on publicly available information

Yaoqin Gong

The Key Laboratory of Experimental Teratology of the Ministry of Education and Department of Genetics, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in Cancer Cell
Verified
Journal Article
Closed access
HHHuili Hu
Huili Hu
YYYang Yang
Yang Yang
QJQinghong Ji
Qinghong Ji
WZWei Zhao
Wei Zhao
BJBaichun Jiang
Baichun Jiang
YGYaoqin Gong
Yaoqin Gong

1 March 2007 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
YZYongxin Zou
Yongxin Zou
QLQiji Liu
Qiji Liu
BCBingxi Chen
Bingxi Chen
XZXiyu Zhang
Xiyu Zhang
CGChenhong Guo
Chenhong Guo
YGYaoqin Gong
Yaoqin Gong

1 December 2008 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
PLPengfei Lin
Pengfei Lin
JLJianwei Li
Jianwei Li
QLQiji Liu
Qiji Liu
FMFei Mao
Fei Mao
JLJisheng Li
Jisheng Li
YGYaoqin Gong
Yaoqin Gong

1 November 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
YZYongxin Zou
Yongxin Zou
JMJun Mi
Jun Mi
JCJinpeng Cui
Jinpeng Cui
DLDefen Lu
Defen Lu
XZXiyu Zhang
Xiyu Zhang
YGYaoqin Gong
Yaoqin Gong
CUL4A and CUL4B, which are derived from the same ancestor, CUL4, encode scaffold proteins that organize cullin-RING ubiquitin ligase (E3) complexes. Recent genetic studies have shown that germ line mutation in CUL4B can cause mental retardation, short stature, and other abnormalities in humans. CUL4A was observed to be overexpressed in breast and hepatocellular cancers, although no germ line mutation in human CUL4A has been reported. Although CUL4A has been known to be involved in a number of cellular processes, including DNA repair and cell cycle regulation, little is known about whether CUL4B has similar functions. In this report, we tested the functional importance of CUL4B in cell proliferation and characterized the nuclear localization signal (NLS) that is essential for its function. We found that RNA interference silencing of CUL4B led to an inhibition of cell proliferation and a prolonged S phase, due to the overaccumulation of cyclin E, a substrate targeted by CUL4B for ubiquitination. We showed that, unlike CUL4A and other cullins that carry their NLS in their C termini, NLS in CUL4B is located in its N terminus, between amino acid 37 and 40, KKRK. This NLS could bind to importin α1, α3, and α5. NLS-deleted CUL4B was distributed in cytoplasm and failed to promote cell proliferation. Therefore, the nuclear localization of CUL4B mediated by NLS is critical for its normal function in cell proliferation.

1 November 2019 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
HDHao Dou
Hao Dou
YDYuyao Duan
Yuyao Duan
XZXiaohui Zhang
Xiaohui Zhang
QYQian Yu
Qian Yu
QDQian Di
Qian Di
YGYaoqin Gong
Yaoqin Gong
Peroxisome proliferator-activated receptor γ (PPARγ) is the central regulator of adipogenesis, and its dysregulation is linked to obesity and metabolic diseases. Identification of the factors that regulate PPARγ expression and activity is therefore crucial for combating obesity. Aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor with a known role in xenobiotic detoxification. Recent studies have suggested that AhR also plays essential roles in energy metabolism. However, the detailed mechanisms remain unclear. We previously reported that experiments with adipocyte-specific Cullin 4b (Cul4b)-knockout mice showed that CUL4B suppresses adipogenesis by targeting PPARγ. Here, using immunoprecipitation, ubiquitination, real-time PCR, and GST-pulldown assays, we report that AhR functions as the substrate receptor in CUL4B-RING E3 ubiquitin ligase (CRL4B) complex and is required for recruiting PPARγ. AhR overexpression reduced PPARγ stability and suppressed adipocyte differentiation, and AhR knockdown stimulated adipocyte differentiation in 3T3-L1 cells. Furthermore, we found that two lysine sites on residues 268 and 293 in PPARγ are targeted for CRL4B-mediated ubiquitination, indicating cross-talk between acetylation and ubiquitination. Our findings establish a critical role of AhR in regulating PPARγ stability and suggest that the AhR–PPARγ interaction may represent a potential therapeutic target for managing metabolic diseases arising from PPARγ dysfunction.

8 August 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
QLQiao Liu
Qiao Liu
HJHaiyan Jiang
Haiyan Jiang
ZLZhaojian Liu
Zhaojian Liu
YWYu Wang
Yu Wang
MZMinnan Zhao
Minnan Zhao
Changshun ShaoChangshun Shao
Changshun Shao
Esophageal squamous cell carcinomas (ESCC) have poor prognosis. While combined modality of chemotherapy and radiotherapy increases survival, most patients die within five years. Development of agents that confer cancer cell-specific chemo- and radiosensitivity may improve the therapy of ESCC. We here reported the discovery of berberine as a potent radiosensitizing agent on ESCC cells. Berberine at low concentrations (<15 µM) substantially radiosensitized ESCC cells. X-ray induced DNA double-strand breaks (DSBs) persist longer in ESCC cells pretreated with berberine. Berberine pretreatment led to a significant downregulation of RAD51, a key player in homologous recombination repair, in ESCC cells, but not in non-malignant human cells. Downregulation of RAD51 by RNA interference similarly radiosensitized the cancer cells, and, conversely, introduction of exogenous RAD51 was able to significantly counteract the radiosensitizing effect of berberine, thus establishing RAD51 as a key determinant in radiation sensitivity. We also observed that RAD51 was commonly overexpressed in human ESCC tissues, suggesting that it is necessary to downregulate RAD51 to achieve high radio- or chemotherapeutic efficacy of ESCC in clinic, because overexpression of RAD51 is known to confer radio- and chemoresistance. Berberine can effectively downregulate RAD51 in conferring radiosensitivity on esophageal cancer cells. Its clinical application as an adjuvant in chemotherapy and radiotherapy of esophageal cancers should be explored.